Adjusting the Basal Insulin Regimen of Patients With Type 1 Diabetes Mellitus Receiving Insulin Pump Therapy During the Ramadan Fast: A Case Series in Adolescents and Adults

被引:16
|
作者
Hawli, Yousra M. A. [1 ,2 ]
Zantout, Mira S. [1 ]
Azar, Sami T. [1 ,2 ]
机构
[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Endocrinol, New York, NY 10017 USA
[2] Chron Care Ctr, Beirut, Lebanon
关键词
type; 1; diabetes; Ramadan fasting; insulin pump therapy; blood glucose concentration; diabetes control;
D O I
10.1016/j.curtheres.2009.02.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BACKGROUND: Ramadan, the ninth month of the Islamic lunar calendar, is the holy month of fasting for adolescent and adult Muslims. Observance of Ramadan is considered obligatory for every healthy adult Muslim. During this time, Muslims refrain from eating, drinking, smoking, and administering oral or parenceral medications from sunrise to sunset daily for 28 to 30 days. CASE SUMMARY: We evaluated the need for changes in basal insulin regimen in 5 patients (4 males and 1 female; age range, 15-19 years) with type 1 diabetes mellitus (T1DM) who fasted during Ramadan. The patients were receiving insulin pump therapy with regular human insulin and maintained weekly visits with their endocrinologist at The Chronic Care Center (Beirut, Lebanon). They were instructed to break the fast after any episode of hypoglycemia (finger stick glucose <70 mg/dL) or severe hyperglycemia (finger stick glucose >= 300 mg/dL or any hyperglycemia associated with presence of urine ketone bodies on urinary dipstick). Blood glucose concentrations did not change significantly with fasting. Finger stick blood glucose taken at 4-hour intervals decreased in the afternoon (at 4 PM) and increased in the evening and morning (10 PM and 8 AM, respectively) during this month in 4 of 5 patients, while no significant change in circadian rhythm of finger stick blood glucose was observed in 1 patient. Based on the investigators' findings, the basal insulin requirement decreased by 5.5% to 25.0% (4 patients) or did not change (I patient) during the fast. Changes in regimens, based on collaboration between the endocrinologist and diabetes educational nurse, were determined by blood glucose self-monitoring done at 4-hour intervals during the fasting period, pre-Suhur (predawn breakfast), and >= 2 hours after Iftar (evening fast-breaking meal). No cases of ketoacidosis or severe hypoglycemia were reported. CONCLUSION: These 5 adolescent and adult patients with T1DM who were using an insulin pump were able to fast during Ramadan without incidences of severe hypoglycemia or ketoacidosis by using close blood glucose self-monitoring and weekly
引用
收藏
页码:29 / 34
页数:6
相关论文
共 50 条
  • [21] Multiple Insulin Injections Versus Insulin Pump Therapy to Diabetes Mellitus Type 1
    Liberatore, Raphael Del Roio
    Bellini Ribeiro, Maria Estela
    Martinelli, Carlos Eduardo
    Custodio, Rodrigo
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [22] The Effectiveness and Durability of an Early Insulin Pump Therapy in Children and Adolescents with Type 1 Diabetes Mellitus
    Brancato, Davide
    Fleres, Mattia
    Aiello, Vito
    Saura, Gabriella
    Scorsone, Alessandro
    Ferrara, Lidia
    Provenzano, Francesca
    Di Noto, Anna
    Spano, Lucia
    Provenzano, Vincenzo
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (11) : 735 - 741
  • [23] Initiating basal insulin therapy in patients with type 2 diabetes mellitus
    Stoneking, K
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (05) : 510 - 518
  • [24] The effect of basal insulin dose reduction during exercise in adolescents with type 1 diabetes mellitus
    Sendela, J.
    Szypowska, A.
    Piechowiak, K.
    Dzygalo, K.
    Kowalska, A.
    DIABETOLOGIA, 2014, 57 : S256 - S256
  • [25] Insulin pump therapy in patients with type 1 diabetes
    Minicucci, Walter Jose
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2008, 52 (02) : 340 - 348
  • [26] Important Determinants of Diabetes Control in Insulin Pump Therapy in Patients with Type 1 Diabetes Mellitus
    Deeb, Asma
    Abu-Awad, Samar
    Abood, Salima
    El-Abiary, Mohamed
    Al-Jubeh, Jamal
    Yousef, Hana
    AbdelRahman, Laila
    Al Hajeri, Ahlam
    Mustafa, Huda
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (03) : 166 - 170
  • [27] Variability of Basal Rate Profiles in Insulin Pump Therapy and Association with Complications in Type 1 Diabetes Mellitus
    Laimer, Markus
    Melmer, Andreas
    Mader, Julia K.
    Schuetz-Fuhrmann, Ingrid
    Engels, Heide-Rose
    Goetz, Gabriele
    Pfeifer, Martin
    Hermann, Julia M.
    Stettler, Christoph
    Holl, Reinhard W.
    PLOS ONE, 2016, 11 (03):
  • [28] Insulin-Pump Therapy for Type 1 Diabetes Mellitus REPLY
    Pickup, John C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (04): : 383 - 384
  • [29] Predictors of Optimal Glycemic Control in Children with Diabetes Mellitus Type 1 Receiving Pump Insulin Therapy
    Evsyukova, Evgeniya
    Kolomina, Irina
    Bukin, Sergey
    Kiseleva, Elena
    Latyshev, Oleg
    Okminyan, Goar
    Samsonova, Lyubov
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 268 - 268
  • [30] Continuous glucose monitoring improved glycaemic control in patients with type 1 diabetes during 52 weeks of insulin pump therapy as well as with basal-bolus insulin regimen
    Soupal, J.
    Flekac, M.
    Petruzelkova, L.
    Skrha, J., Jr.
    Skrha, J.
    Prazny, M.
    DIABETOLOGIA, 2015, 58 : S476 - S476